Clinical trial
CONTAK RENEWAL 3 AVT
NCT00158977 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00158977 |
|---|---|
| Title | CONTAK RENEWAL 3 AVT |
| Official title | CONTAK RENEWAL 3 AVT Study |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Atrial Fibrillation |
| Intervention type | Device |
| Interventions | CONTAK RENEWAL 3 AVT |
| Enrollment | 73 |
| Start date | Nov 1, 2003 |
| Primary completion | Oct 1, 2004 |
| Completion | Feb 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: